Skip to main content
. 2017 Apr 6;1(10):590–600. doi: 10.1182/bloodadvances.2017005124

Table 2.

ADAMTS13 functional inhibitor strength measured by FRETS (n = 77)

Inhibitor titer (BU/mL) Patients
No. %
None 13 17
0.5-0.9 14 18
1-2 20 26
>2 30 39

In one of the 78 patients, inhibitor activity was measured only by IB. Among the 13 patients with no inhibitor activity measured by the FRET method, IB inhibitor activity was >2 in 1 patient, <1 to 1 in 4 patients, no inhibitor was documented in 2 patients, and an IB inhibitor measurement was not performed in 6 patients.